Download page as a PDF

Osteocel® – A Complete Allograft.
A Cellular Bone Matrix Product Retaining
MSCs and Osteoprogenitors.

(return to previous page)

Safety Profile

Aseptic tissue processing

Antimicrobial treatment of tissue

Sterility cultures performed on every lot

Selective immunodepletion process

No evidence of ectopic tissue
formation or inflammatory cellular response with experimental high
doses of mesenchymal stem cells.1

Donor Testing

Hepatitis B Surface Antigen

Hepatitis B Core Antibody

Hepatitis C Virus Antibody

Hepatitis C Nucleic Acid Test

HIV-1 and 2 Antibody

HIV-1 Nucleic Acid Test

Human T-Lymphotropic Virus
Antibody I/II

Syphilis (Treponema Pallidum)

Donor Screening

Medical and social history evaluation

Physical examination

Medical record evaluation, including autopsy report (if performed)

Licensed physician review and
release of every donor record

Quality Assurance
GTP compliant according to FDA regulations

State of FL, MD, NY, CA, OR
licensure / registrations

AATB Accreditation

References
1 Data on file with Osiris Therapeutics

Osteocel is a federally registered trademark of NuVasive®, Inc. used by ACE Surgical under licence. Protected by U.S. Patent 5,811,094 and 6,355,239. Other patents pending.